CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 219 enrolled
Drug / intervention
fluticasonedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00705341
NCT00705341Phase 4Completed
CompareCT.gov

MethaCholine Bronchoprovocation - Influence of High Potency Inhaled corticoSteroids in Asthma (MeCIS) Study

Johns Hopkins Bloomberg School of Public Health·interventional·Posted Jun 26, 2008·Updated Feb 12, 2013

In Brief

A Phase 4 clinical trial evaluating fluticasone for Asthma. Completed, enrolled 219 participants across 13 sites.

Detailed Summary

The purpose of this research is to evaluate the methacholine challenge test as an accurate indicator of asthma in patients receiving treatment for asthma. Phase 1 on the study compares methacholine challenge test results from asthma patients to those from people who do not have asthma. In phase 2, test results for people with asthma on low dose inhaled corticosteroid will be compared to results on high dose inhaled corticosteroids. Both males and females with stable asthma (asthma participants) and without asthma (controls) enrolled. Participants will be between 12 and 69 years of age.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesUnited States
CollaboratorsWashington University School of Medicine, St. Louis University, Long Island Jewish Medical Center, North Shore University Hospital, Baylor College of Medicine, University of Vermont, Nemours Children's Clinic, University of Florida, Indiana University, Ohio State University, NYU Langone Health, University of Missouri-Columbia, Northwestern University, Louisiana State University Health Sciences Center in New Orleans, University of Miami, University of South Florida, University of California, San Diego, National Jewish Health, Duke University

Timeline

Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 26, 2008
Enrollment StartJan 1, 2009
Primary CompletionFeb 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 18.0 years ago

Interventions

fluticasonedrug

Inhaled corticosteroid approved for treatment of asthma